INS and metabolic disease: contributes to epithelial barrier protection, supports maintenance of the mucus layer, and improves metabolic disorders (such as diabetes) through multiple mechanisms, including stimulation of glucagon-like peptide-1 (GLP-1) secretion by intestinal L cells, which promotes insulin production [37,38].